Literature DB >> 2659533

Effector cells involved in nonspecific and antibody-dependent mechanisms directed against Plasmodium falciparum blood stages in vitro.

F Lunel1, P Druilhe.   

Abstract

We have evaluated in in vitro conditions the possible cooperative effect of antimalarial antibodies with several human blood cell types. When used alone, immunoglobulin G from African adults who had reached a state of premunition against malaria was found to have no or very limited direct effect on invasion and multiplication of P. falciparum asexual blood stages. In contrast, these antibodies induced a marked specific inhibition of parasite growth in the presence of normal blood monocytes, and the inhibition did not appear to be strain dependent. No similar antibody-dependent cellular inhibitory effect was found using human blood polymorphonuclear leukocytes, lymphocytes, platelets, or adherent spleen cells. However, these cells could all exert in vitro some non-antibody-dependent inhibitory effect when present at high effector/target cell ratios.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2659533      PMCID: PMC313839          DOI: 10.1128/iai.57.7.2043-2049.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

Review 1.  THE PASSIVE TRANSFER OF HUMAN MALARIAL IMMUNITY.

Authors:  I A MCGREGOR
Journal:  Am J Trop Med Hyg       Date:  1964-01       Impact factor: 2.345

2.  Gamma-globulin and acquired immunity to human malaria.

Authors:  S COHEN; I A McGREGOR; S CARRINGTON
Journal:  Nature       Date:  1961-11-25       Impact factor: 49.962

3.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

4.  Enhanced inhibition of in vitro multiplication of Plasmodium falciparum by stimulated human polymorphonuclear leucocytes.

Authors:  A Kharazmi; S Jepsen
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

5.  Inhibition of the in vitro growth of Plasmodium falciparum. I. The effects of immune serum and purified immunoglobulin from owl monkeys.

Authors:  R T Reese; M R Motyl
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

6.  Polymorphonuclear leucocytes defective in oxidative metabolism inhibit in vitro growth of Plasmodium falciparum. Evidence against an oxygen-dependent mechanism.

Authors:  A Kharazmi; S Jepsen; N H Valerius
Journal:  Scand J Immunol       Date:  1984-07       Impact factor: 3.487

7.  Longitudinal study on the in vitro immune response to Plasmodium falciparum in Sudan.

Authors:  J A Vande Waa; J B Jensen; M A Akood; R Bayoumi
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

8.  Cellular mechanisms involved in recovery from acute malaria in Gambian children.

Authors:  J Brown; B M Greenwood; R J Terry
Journal:  Parasite Immunol       Date:  1986-11       Impact factor: 2.280

9.  Comparison of immunity to malaria in Sudan and Indonesia: crisis-form versus merozoite-invasion inhibition.

Authors:  J B Jensen; S L Hoffman; M T Boland; M A Akood; L W Laughlin; L Kurniawan; H A Marwoto
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

10.  Specific antibody-dependent cellular cytotoxicity in human malaria.

Authors:  J Brown; M E Smalley
Journal:  Clin Exp Immunol       Date:  1980-09       Impact factor: 4.330

View more
  21 in total

1.  Plasmodium falciparum malaria: evidence for an isotype imbalance which may be responsible for delayed acquisition of protective immunity.

Authors:  H Bouharoun-Tayoun; P Druilhe
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

Review 2.  Transgenic rodent Plasmodium berghei parasites as tools for assessment of functional immunogenicity and optimization of human malaria vaccines.

Authors:  Godfree Mlambo; Nirbhay Kumar
Journal:  Eukaryot Cell       Date:  2008-09-19

3.  Novel target antigens of the variant-specific immune response to Plasmodium falciparum identified by differential screening of an expression library.

Authors:  C Le Scanf; T Fandeur; S Bonnefoy; M Guillotte; O Mercereau-Puijalon
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

4.  The glutamate-rich protein (GLURP) of Plasmodium falciparum is a target for antibody-dependent monocyte-mediated inhibition of parasite growth in vitro.

Authors:  M Theisen; S Soe; C Oeuvray; A W Thomas; J Vuust; S Danielsen; S Jepsen; P Druilhe
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

5.  Anti-idiotypic antibodies counteract the invasion inhibition capacity of antibodies to major epitopes of the Plasmodium falciparum antigen Pf155/RESA.

Authors:  B Wåhlin; K Berzins; H Perlmann; R F Anders; P Perlmann
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

6.  Association between protection against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendemicity in Myanmar: complementarity between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich protein.

Authors:  Soe Soe; Michael Theisen; Christian Roussilhon; Khin-Saw Aye; Pierre Druilhe
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

7.  Platelet-mediated clumping of Plasmodium falciparum infected erythrocytes is associated with high parasitemia but not severe clinical manifestations of malaria in African children.

Authors:  Mònica Arman; Ahmed Raza; Louisa J Tempest; Kirsten E Lyke; Mahamadou A Thera; Abdoulaye Koné; Christopher V Plowe; Ogobara K Doumbo; J Alexandra Rowe
Journal:  Am J Trop Med Hyg       Date:  2007-11       Impact factor: 2.345

8.  Clinical protection from falciparum malaria correlates with neutrophil respiratory bursts induced by merozoites opsonized with human serum antibodies.

Authors:  Charlotte Joos; Laurence Marrama; Hannah E J Polson; Sandra Corre; Antoine-Marie Diatta; Babacar Diouf; Jean-François Trape; Adama Tall; Shirley Longacre; Ronald Perraut
Journal:  PLoS One       Date:  2010-03-25       Impact factor: 3.240

9.  Long-term multiepitopic cytotoxic-T-lymphocyte responses induced in chimpanzees by combinations of Plasmodium falciparum liver-stage peptides and lipopeptides.

Authors:  Lbachir BenMohamed; Alan Thomas; Pierre Druilhe
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

10.  Humoral responses to Plasmodium falciparum blood-stage antigens and association with incidence of clinical malaria in children living in an area of seasonal malaria transmission in Burkina Faso, West Africa.

Authors:  Issa Nebie; Amidou Diarra; Alphonse Ouedraogo; Issiaka Soulama; Edith C Bougouma; Alfred B Tiono; Amadou T Konate; Roma Chilengi; Michael Theisen; Daniel Dodoo; Ed Remarque; Samuel Bosomprah; Paul Milligan; Sodiomon B Sirima
Journal:  Infect Immun       Date:  2007-12-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.